Performance evaluation of nanoclay enriched anti-microbial hydrogels for biomedical applications

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Nanotechnology

Background:

• Post-surgical infections and bacterial biofilm formation are major causes of orthopedic and orthodontic implant failure.
• Current anti-microbial coatings have limitations, including unpredictable drug release and incomplete prevention of biofilm formation.

Purpose of the Study:

• To develop a novel hydrogel composite for enhanced anti-microbial delivery and improved implant integration.
• To investigate the sustained release of gentamicin sulfate from halloysite nanotubes (HNTs) within a calcium alginate and calcium phosphate cement (CPC) hydrogel.
• To evaluate the anti-bacterial efficacy and osteoblast compatibility of the developed composite material.

Main Methods:

• Fabrication of a calcium alginate and calcium phosphate cement (CPC) hydrogel composite.
• Loading of gentamicin sulfate into halloysite nanotubes (HNTs) and enrichment of the hydrogel.
• Assessment of gentamicin sulfate release kinetics over five days.
• Evaluation of the composite's anti-bacterial activity against gram-negative bacteria using zone of inhibition assays.
• In vitro pilot study using mouse osteoblasts to assess cell proliferation and matrix production.

Main Results:

• The gentamicin-loaded HNT-enriched hydrogels demonstrated sustained and extended release of gentamicin sulfate.
• The hydrogel/nanoclay composites exhibited significant anti-bacterial activity, creating a pronounced zone of inhibition against gram-negative bacteria.
• Osteoblast pilot studies confirmed the biocompatibility of the nanoclay-enriched surfaces, showing robust cell proliferation and matrix production.

Conclusions:

• The developed hydrogel/nanoclay composite provides a promising platform for sustained and controlled delivery of anti-microbial agents, effectively preventing bacterial growth and biofilm formation on implant surfaces.
• The material's biocompatibility with osteoblasts suggests its potential for enhancing osseointegration and improving the long-term success of orthopedic implants.
• This approach offers a significant advancement in combating implant-associated infections and improving patient outcomes.